Carbidopa and Levodopa ODT

Dosage form: tablet, orally disintegrating
Drug class:Dopaminergic antiparkinsonism agents

Medically reviewed by Drugs.com. Last updated on Sep 21, 2021.

Carbidopa and Levodopa ODT Description

Carbidopa and levodopa orally disintegrating tablet is a combination of carbidopa and levodopa for the treatment of Parkinson’s disease and syndrome. Carbidopa and levodopa orally disintegrating tablet is an orally administered formulation of carbidopa and levodopa which rapidly disintegrates on the tongue and does not require water to aid dissolution or swallowing.

Carbidopa USP, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, with a molecular weight of 244.24. It is designated chemically as (-)-L-α-hydrazino-α-methyl-β-(3,4-dihydroxybenzene) propanoic acid monohydrate. Its empirical formula is C10H14N2O4.H2O, and its structural formula is:

Tablet content is expressed in terms of anhydrous carbidopa which has a molecular weight of 226.23.

Levodopa USP, an aromatic amino a...